Abstract
During the period November 1976 to September 1980, 2703 babies born in one Edinburgh hospital were screened in the neonatal period by estimation of their serum creatine kinase levels for Duchenne muscular dystrophy. Among the 2336 male babies tested, none proved to be affected and only 16 required second specimens to be obtained. Overall the false positive rate in the study was 0.78%. This study confirms that neonatal screening for Duchenne muscular dystrophy is feasible in a British hospital setting and is here most conveniently carried out on the 5th day of life along with routine testing for phenylketonuria.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnold H., Löhr G. W., Scheuerbrandt G., Beckmann R. Creatine kinase in human erythrocytes: a newly detected genetic anomaly. Blut. 1978 Nov 13;37(5):249–256. doi: 10.1007/BF01539660. [DOI] [PubMed] [Google Scholar]
- Berglund G., Sannerstedt R., Andersson O., Wedel H., Wilhelmsen L., Hansson L., Sivertsson R., Wikstrand J. Coronary heart-disease after treatment of hypertension. Lancet. 1978 Jan 7;1(8054):1–5. doi: 10.1016/s0140-6736(78)90356-2. [DOI] [PubMed] [Google Scholar]
- Dellamonica C., Robert J. M., Cotte J., Plauchu H., Dorche C. Dépistage néonatal systématique de la myopathie de Duchenne de Boulogne (author's transl)] Nouv Presse Med. 1979 Apr 21;8(18):1491–1493. [PubMed] [Google Scholar]
- Drummond L. M. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch Dis Child. 1979 May;54(5):362–366. doi: 10.1136/adc.54.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emery A. E., Burt D., Dubowitz V., Rocker I., Donnai D., Harris R., Donnai P. Antenatal diagnosis of Duchenne muscular dystrophy. Lancet. 1979 Apr 21;1(8121):847–849. doi: 10.1016/s0140-6736(79)91264-9. [DOI] [PubMed] [Google Scholar]
- Emery A. E., Skinner R. Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet. 1976 Oct;10(4):189–201. doi: 10.1111/j.1399-0004.1976.tb00033.x. [DOI] [PubMed] [Google Scholar]
- Emery A. E., Watt M. S., Clack E. R. The effects of genetic counselling in Duchenne muscular dystrophy. Clin Genet. 1972;3(2):147–150. doi: 10.1111/j.1399-0004.1972.tb01736.x. [DOI] [PubMed] [Google Scholar]
- Heyck H., Laudahn G., Carsten P. M. Enzymaktivitätsbestimmungen bei Dystrophia musculorum progressiva. IV. Die Serumenzymkinetik im präklinischen Stadium des Typus Duchenne während der ersten 2 Lebensjahre. Klin Wochenschr. 1966 Jun 15;44(12):695–700. doi: 10.1007/BF01790793. [DOI] [PubMed] [Google Scholar]
- Janeway C. A. Screening for inherited diseases. N Engl J Med. 1971 Apr 8;284(14):787–788. doi: 10.1056/NEJM197104082841409. [DOI] [PubMed] [Google Scholar]
- PEARSON C. M. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase. N Engl J Med. 1957 Jun 6;256(23):1069–1075. doi: 10.1056/NEJM195706062562301. [DOI] [PubMed] [Google Scholar]
- Zellweger H., Antonik A. Newborn screening for Duchenne muscular dystrophy. Pediatrics. 1975 Jan;55(1):30–34. [PubMed] [Google Scholar]